Vaccines: Use case
Use cases
Each use, its share of demand and volume, how critical the product is to it and why, and the price paid
| Use case | Share of demand | Volume | Unit | Criticality | Reason | Year | Source |
|---|---|---|---|---|---|---|---|
| Routine childhood immunisation in countries supplied through UNICEF | – | 2.79 billion | doses UNICEF delivered to 99 countries | Essential | Judgement: no medicine replaces prevention for most vaccine-preventable diseases; WHO says vaccination accounts for 40% of the fall in infant deaths worldwide. | 2024 | [4][1] |
| Self-procuring middle-income countries (share of 2023 market volume, approximately) | 40% | – | – | Essential | Judgement: national programmes buy for routine schedules. | 2023 | [2] |
| Pooled procurement by UNICEF and PAHO (share of globally procured volume) | 36% | – | – | Essential | Judgement: pooled buying supplies low-income and Gavi-supported programmes. | 2023 | [2] |
| Self-procuring high-income countries (the remaining share of 2023 market volume) | 24% | – | – | Essential | Judgement: national programmes buy for routine schedules; this group holds 72% of market value. | 2023 | [2] |
| India's Universal Immunisation Programme, free immunisation against 12 diseases: newborns targeted a year (2.67 crore) | – | 26.7 million | newborns targeted a year (calculated: 2.67 crore converted) | Essential | Judgement: the state programme is the main route to immunisation for most Indian children. | 2024 | [14] |
| India's Universal Immunisation Programme: pregnant women targeted a year (2.9 crore) | – | 29 million | pregnant women targeted a year (calculated: 2.9 crore converted) | Essential | Judgement: the state programme gives the vaccines in routine antenatal care. | 2024 | [14] |
| Outbreak response from Gavi-supported emergency stockpiles | – | 63 | uses of Gavi-supported emergency stockpiles (cholera, Ebola, meningococcal and yellow fever vaccines) by 19 countries | Important | Judgement: stockpiles are for outbreaks; routine programmes cover most doses. | 2025 | [13] |
as of 2026-11-14
Industries that buy it
The industries and kinds of firm that buy it, for which use case, and how critical it is to them
Used by- Healthcare services Immunisation of children and pregnant women · criticality essential Health workers carry vaccines from the country store to villages in cold boxes and vaccine carriers [10]; no share of demand by facility type was found.
as of 2026-11-14
What it competes with
The products and technologies that compete with it in each use case
Competes with- Antibiotic medicines Preventing bacterial infections and the antibiotic use that follows Only a partial swap, for the diseases that have a vaccine. WHO estimates that vaccines against 23 pathogens, including some still to be developed, could reduce the number of antibiotics needed by 22%, or 2.5 billion defined daily doses a year [26]; no cost comparison was found.
as of 2026-11-14
How it is used
Lifetime, use per year and utilisation, by variant
| Measure | Value | Unit | Place | Year | Source |
|---|---|---|---|---|---|
| Vaccine wastage assumed in UNICEF's costing, BCG (20-dose vial) | 54 | % of doses | World (Gavi-eligible countries) | 2024 | [8] |
| Vaccine wastage assumed in UNICEF's costing, pneumococcal conjugate (4-dose vial) | 17 | % of doses | World (Gavi-eligible countries) | 2024 | [8] |
| Wastage at service delivery points (the study's last cold chain point), measles vaccine | 31.47 | % of doses | India | 2019 | [16] |
| Wastage at service delivery points (the study's last cold chain point), BCG vaccine | 56.83 | % of doses | India | 2019 | [16] |
| Wastage at service delivery points (the study's last cold chain point), pneumococcal conjugate vaccine | 0.24 | % of doses | India | 2019 | [16] |
| Wastage by vial size: vaccines in 10-dose vials (BCG, pentavalent, rotavirus, JE, DPT, TT) | 33.61 | % of doses | India | 2019 | [16] |
| Wastage by vial size: vaccines in vials of 5 doses or fewer (measles, PCV) | 15.91 | % of doses | India | 2019 | [16] |
| Vaccine doses recorded on India's U-WIN platform as of 16 September 2024 (calculated: 23.06 crore converted) | 231 million | doses (converted from crore) | India | 2024 | [14] |
as of 2026-11-14
Prices
Unit prices by market or use, with year and source
| Market | Value | Unit | Year | Source |
|---|---|---|---|---|
| UNICEF price for Gavi-eligible countries, oral polio vaccine | 0.14 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, DTP vaccine (second year of life) | 0.19 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, BCG vaccine | 0.2 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, measles-rubella vaccine | 0.82 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, pentavalent vaccine | 0.84 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, injectable polio vaccine | 2.1 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, rotavirus vaccine | 2.22 | US$ per dose | 2024 | [8] |
| UNICEF price for Gavi-eligible countries, pneumococcal conjugate vaccine (PCV13) | 2.75 | US$ per dose | 2024 | [8] |
| Average cost of fully vaccinating one child (eleven diseases, Gavi-eligible countries; range US$45.51 to US$129.57) | 73.15 | US$ per child | 2024 | [8] |
| High-income countries' share of the world market's financial value | 72 | % of value | 2023 | [2] |
as of 2026-11-14
Sources
- Global vaccine market report 2024 World Health Organization, 2024, landing page, published 19 December 2024; data for 2023; WHO lists a final version (B09198, 3 February 2025)
- WHO releases global vaccine market report 2024 Immunization Economics (summary of the WHO report), 2025, 17 February 2025
- UNICEF Supply Annual Report 2024 UNICEF Supply Division, 2025
- Costs of Fully Vaccinating a Child: Countries Eligible for Gavi Vaccine Prices UNICEF, 2024, August 2024; Tables 1 and 4
- What is a cold chain? UNICEF Supply Division
- Facts and figures Gavi, the Vaccine Alliance, 2026, figures for 2000 to 2025
- World Immunization Day 2024: India's Immunization Drive: A Commitment to Universal Vaccine Coverage and Health Equity Ministry of Health and Family Welfare, Government of India (PIB), 2024, 7 November 2024
- National Vaccine Wastage Assessment 2019 NCCVMRC-NIHFW and UNICEF India, 2019, fieldwork February to March 2019 on a review period of April to September 2018; Tables 2, 6 and 11 and section 4.1
- Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO World Health Organization, 2024, 10 October 2024